Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592532 | SCV000703837 | uncertain significance | not provided | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001246416 | SCV001419770 | uncertain significance | Peroxisome biogenesis disorder | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 928 of the PEX6 protein (p.Arg928His). This variant is present in population databases (rs201265954, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PEX6-related conditions. ClinVar contains an entry for this variant (Variation ID: 498696). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PEX6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000592532 | SCV001989790 | uncertain significance | not provided | 2019-06-04 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002476295 | SCV002786995 | uncertain significance | Peroxisome biogenesis disorder 4A (Zellweger); Peroxisome biogenesis disorder 4B; Heimler syndrome 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834878 | SCV002077264 | uncertain significance | Zellweger spectrum disorders | 2019-10-28 | no assertion criteria provided | clinical testing |